Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.
Principal International Equity Index R1 PILIX
- NAV / 1-Day Return 11.11 / +1.09 %
- Total Assets 1.1 Bil
-
Adj. Expense Ratio
- Expense Ratio 1.210%
- Distribution Fee Level Below Average
- Share Class Type Retirement, Medium
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment —
- Status Limited
- TTM Yield 1.57%
- Turnover 38%
USD | NAV as of Apr 23, 2024 | 1-Day Return as of Apr 23, 2024, 10:14 PM GMT+0
Morningstar’s Analysis PILIX
Will PILIX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 15.2
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk A/S Class B | 2.44 | 29.2 Mil | Healthcare |
ASML Holding NV | 2.28 | 27.3 Mil | Technology |
Nestle SA | 1.65 | 19.8 Mil | Consumer Defensive |
Toyota Motor Corp | 1.56 | 18.7 Mil | Consumer Cyclical |
Lvmh Moet Hennessy Louis Vuitton SE | 1.45 | 17.3 Mil | Consumer Cyclical |
Shell PLC | 1.26 | 15.1 Mil | Energy |
AstraZeneca PLC | 1.21 | 14.5 Mil | Healthcare |
SAP SE | 1.19 | 14.2 Mil | Technology |
Novartis AG Registered Shares | 1.16 | 13.9 Mil | Healthcare |
Roche Holding AG | 1.05 | 12.5 Mil | Healthcare |